Thursday, November 02, 2017 10:15 PM ET
Insider Selling at Biohaven Pharmaceutical Holding (BHVN) is Significant
One Biohaven Pharmaceutical Holding insider — Vlad Coric, Director and Officer — today, disposed of 123,950 shares having a market value of approximately $3,648,698, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.
This number of buy-sell trades at Biohaven Pharmaceutical Holding is near average for the 185 member peer company. The Biotechnology & Medical Research peer group saw 209 buy/sell trades during this period for an average of 1.1 transactions per company. However, trading at Biohaven Pharmaceutical Holding represents a lower number of shares per transaction. Within the peer group there were 23,152,301 shares purchased and 51,262,333 shares sold with company insiders selling 134,498 shares on average over this time period.
The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.